Aptorum Group (APM) Competitors $1.07 -0.07 (-5.73%) Closing price 03:54 PM EasternExtended Trading$1.10 +0.02 (+2.34%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock APM vs. SXTC, OVID, NAII, SLGL, BIVI, CGTX, CMMB, ASBP, LGVN, and ELEVShould you be buying Aptorum Group stock or one of its competitors? The main competitors of Aptorum Group include China SXT Pharmaceuticals (SXTC), Ovid Therapeutics (OVID), Natural Alternatives International (NAII), Sol-Gel Technologies (SLGL), BioVie (BIVI), Cognition Therapeutics (CGTX), Chemomab Therapeutics (CMMB), Aspire Biopharma (ASBP), Longeveron (LGVN), and Elevation Oncology (ELEV). These companies are all part of the "pharmaceutical products" industry. Aptorum Group vs. China SXT Pharmaceuticals Ovid Therapeutics Natural Alternatives International Sol-Gel Technologies BioVie Cognition Therapeutics Chemomab Therapeutics Aspire Biopharma Longeveron Elevation Oncology Aptorum Group (NASDAQ:APM) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, community ranking, media sentiment, analyst recommendations, dividends and profitability. Which has higher earnings & valuation, APM or SXTC? Aptorum Group has higher earnings, but lower revenue than China SXT Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptorum Group$430K13.31-$2.83MN/AN/AChina SXT Pharmaceuticals$1.82M18.37-$3.10MN/AN/A Is APM or SXTC more profitable? Company Net Margins Return on Equity Return on Assets Aptorum GroupN/A N/A N/A China SXT Pharmaceuticals N/A N/A N/A Does the media prefer APM or SXTC? In the previous week, China SXT Pharmaceuticals had 1 more articles in the media than Aptorum Group. MarketBeat recorded 2 mentions for China SXT Pharmaceuticals and 1 mentions for Aptorum Group. Aptorum Group's average media sentiment score of 0.00 equaled China SXT Pharmaceuticals'average media sentiment score. Company Overall Sentiment Aptorum Group Neutral China SXT Pharmaceuticals Neutral Which has more volatility and risk, APM or SXTC? Aptorum Group has a beta of -0.14, suggesting that its stock price is 114% less volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Does the MarketBeat Community believe in APM or SXTC? China SXT Pharmaceuticals received 41 more outperform votes than Aptorum Group when rated by MarketBeat users. However, 68.33% of users gave Aptorum Group an outperform vote while only 61.65% of users gave China SXT Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAptorum GroupOutperform Votes4168.33% Underperform Votes1931.67% China SXT PharmaceuticalsOutperform Votes8261.65% Underperform Votes5138.35% Do insiders and institutionals believe in APM or SXTC? 3.8% of Aptorum Group shares are held by institutional investors. Comparatively, 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. 64.0% of Aptorum Group shares are held by insiders. Comparatively, 4.0% of China SXT Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryChina SXT Pharmaceuticals beats Aptorum Group on 6 of the 9 factors compared between the two stocks. Get Aptorum Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APM vs. The Competition Export to ExcelMetricAptorum GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.72M$6.83B$5.57B$8.67BDividend YieldN/A2.50%5.27%4.19%P/E RatioN/A8.7927.2020.17Price / Sales13.31263.51412.92161.90Price / CashN/A65.8538.2534.64Price / Book0.366.677.114.72Net Income-$2.83M$143.49M$3.23B$247.80M7 Day Performance3.38%6.34%4.61%3.36%1 Month Performance24.29%15.43%13.35%9.71%1 Year Performance-76.22%6.87%31.75%14.41% Aptorum Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APMAptorum Group1.1087 of 5 stars$1.07-5.7%N/A-74.2%$5.72M$430,000.000.0030SXTCChina SXT Pharmaceuticals0.5743 of 5 stars$1.32-5.0%N/A-78.6%$20.89M$1.82M0.0090OVIDOvid Therapeutics4.3067 of 5 stars$0.29+6.5%$2.78+860.1%-88.8%$20.62M$548,000.00-0.6260Gap UpNAIINatural Alternatives International0.3899 of 5 stars$3.31-0.4%N/A-47.5%$20.43M$125.48M-2.56290Positive NewsSLGLSol-Gel Technologies1.7369 of 5 stars$7.32+1.5%$40.00+446.7%-13.1%$20.38M$12.10M-21.5250BIVIBioVie1.4718 of 5 stars$1.07+2.9%$3.00+180.4%+159.9%$19.86MN/A-0.1110CGTXCognition Therapeutics2.6625 of 5 stars$0.32+32.6%$5.63+1,674.4%-84.5%$19.65MN/A-0.3320High Trading VolumeCMMBChemomab Therapeutics3.0348 of 5 stars$1.35+2.3%$8.50+529.6%+29.4%$19.39MN/A-1.3520Positive NewsASBPAspire BiopharmaN/A$0.39-10.5%N/AN/A$19.07MN/A0.00N/ANews CoverageGap UpLGVNLongeveron3.2739 of 5 stars$1.25+0.8%$8.67+593.3%+22.1%$18.66M$2.23M-0.2020News CoverageGap UpELEVElevation Oncology2.5754 of 5 stars$0.31+3.7%$3.39+987.6%-89.1%$18.44MN/A-0.3840Trending NewsAnalyst Forecast Related Companies and Tools Related Companies SXTC Competitors OVID Competitors NAII Competitors SLGL Competitors BIVI Competitors CGTX Competitors CMMB Competitors ASBP Competitors LGVN Competitors ELEV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APM) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump Nominates “Next Elon”Elon's Replacement? You've been told Elon Musk has been forced out of DC. But did you know his successor ha...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptorum Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptorum Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
